Image (08731c4e 5c0c 4fba B250 Dbd17fd36e6e 01)
Valsartan Tablet, Film Coated
Product Images NDC 72789-553
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 72789-553). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (08731c4e 5c0c 4fba B250 Dbd17fd36e6e 02)
This is a statistical comparison of subgroups within the patient population. The data includes information on different demographics such as age, gender, ethnicity (Caucasian vs. Non-Caucasian), location (US vs. Non-US), and medication usage (Beta-blocker vs. No Beta-blocker). The study involves a comparison between Valsartan and Captopril, showing the distribution of patients within each subgroup. The numbers indicate the percentage of patients in each category.*
727895539 Label (72789553)
This is a description of a medication called Valsartan Tablets, USP with a strength of 40 mg. The tablets are film-coated and come in a package of 90 tablets. The dosage information should be referenced in the package insert. The package is child-resistant and should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). It is important to protect the medication from moisture and dispense it in a tight container. The source of this medication is Zydus Pharmaceuticals Ltd. in Ahmedabad, India. For any product inquiries, contact PD-Rx Pharmaceuticals, Inc. in Oklahoma City.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
